|
|
|
|
|
|
Andrew Freedman
Andrew Freedman, PhD, has been an Epidemiologist in the Risk Factor Monitoring and
Methods Branch of the Applied Research Program since December of 1997. He previously
completed a postdoctoral fellowship in the Genetic Epidemiology Branch of the Division of
Cancer Epidemiology and Genetics at the National Cancer Institute. Dr. Freedman received
his PhD in Experimental Pathology from the Roswell Park Cancer Institute Division of the
University of Buffalo in 1995, his MS in Epidemiology from the Department of Social and
Preventive Medicine at the University of Buffalo in 1992, and graduated with a BS in
biology from the University of Binghamton in 1987. His recent research involves developing
cancer prediction models for risk and prognosis, and examining the population impact of
pharmaceuticals on the cancer burden.
|
|
